Economic consequences of multiple sclerosis for Canadians

Acta Neurologica Scandinavica
C V AscheP C Coyte

Abstract

To estimate the total costs of multiple sclerosis (MS) for all Canadians in 1994. Prevalence-based study estimating disease-related societal costs for Canadians with MS in 1994. The human capital approach was used to estimate the value of lost productivity due to illness. Two components were revealed: first, direct costs, in terms of expenditures on hospital care, other institutions, physician services, other health professionals, drugs, and other expenditures; and second, indirect costs, in terms of lost productivity due to premature mortality and disability. The total costs of MS for Canadians were $502.3 million in 1994, with direct and indirect cost components at $188.6 million and $313.7 million, respectively. This study highlights the scope and magnitude of the economic consequences of MS for Canadians. The costs calculated may be used to provide guidance in the setting of national priorities for research and prevention activities.

References

Feb 1, 1975·Acta Neurologica Scandinavica·J F Kurtzke
Jan 1, 1992·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·M Catanzaro, C Weinert
Jan 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·M H RobertsA J Spackman
Jan 1, 1991·Neuroepidemiology·J F Kurtzke
Jan 1, 1985·Journal of Chronic Diseases·N LaroccaP Kendall
Jan 1, 1986·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·A B KornblithH M Baum
Feb 1, 1986·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·V P SweeneyV Brandejs
Nov 4, 1982·The New England Journal of Medicine·D E McFarlin, H F McFarland
Oct 1, 1981·Neurology·J S FeigensonN G LaRocca
Feb 1, 1993·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A D Sadovnick, G C Ebers
Mar 1, 1994·Clinical Biomechanics·C ReinschmidtG R Hamilton

❮ Previous
Next ❯

Citations

Apr 21, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Berto PZaffaroni M
Dec 23, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E OrlewskaA Czlonkowska
Jan 1, 2009·ClinicoEconomics and Outcomes Research : CEOR·Ceri J Phillips, Ioan Humphreys
Sep 17, 2008·PharmacoEconomics·Paul McCroneAlan Thompson
Apr 21, 2010·PharmacoEconomics·Huseyin NaciAmy Duhig
Aug 25, 2010·Drugs·Jessica SharacRamon Sabes-Figuera
Dec 3, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Uwe K ZettlPeter Flachenecker
Apr 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Ewa Orlewska
Apr 14, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Bruce TaylorAriel Beresniak
Jul 16, 2016·BMC Public Health·Emily J Callander, Deborah J Schofield
Jul 15, 2016·PloS One·Olivia ErnstssonAnders Norlund
Apr 25, 2000·Multiple Sclerosis : Clinical and Laboratory Research·D T GrimaL Lafortune
Dec 1, 2002·Expert Review of Pharmacoeconomics & Outcomes Research·Steven B Duff, Margaret M Mordin
Dec 4, 2004·Journal of Health Psychology·Marita P McCabew, Margaret De Judicibus
Sep 30, 2000·PharmacoEconomics·M Kendrick, K I Johnson
Jan 21, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Deborah J SchofieldSimon J Kelly
Sep 13, 2019·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Gauruv BoseMark S Freedman
May 30, 1998·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·M R Del Bigio
Aug 26, 1998·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·L S RobsonP O'Connor
May 31, 2003·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·K D BuscheL M Metz
Jan 27, 2021·Journal of the Neurological Sciences·Gauruv Bose, Mark S Freedman
Feb 24, 2004·Revue neurologique·J GrimaudUNKNOWN Collectif SEP des villes et SEP des champs
Sep 29, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Dirk SchrieferTjalf Ziemssen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.